Diabetes and Endocrinology Center

Request Appointment

(813)-821-8011

Refer a Patient

USF Osteoporosis program 

Osteoporosis and osteoporotic fractures are serious problems worldwide. Approximately 10 million Americans have osteoporosis and another 44 million have low bone density, placing them at an increased risk. It is estimated that ~50% of women and ~20% of men older then 50 years old will have an osteoporosis-related fracture and the number of Americans at risk of fractures is projected to increase. Osteoporotic fractures in elderly often lead to hospitalization followed by long-term care. Hip fracture in older people is the most devastating and can be a very serious problem due to the consequent substantial impact on the activities of daily living, independence, quality of life, accommodation, and increased mortality.  

USF Osteoporosis program has been started based on the growing need in bone health care in the Tampa area, which has one of the highest rates of bone fractures in the United States with the goal to provide primary and secondary fracture prevention.  

The goals of the program are:

  • to prevent not only the next fracture but to avoid the first fracture from happening
  • to screen as many eligible people for osteoporosis as possible
  • to provide an evaluation of possible causes of bone loss
  • to provide treatment and follow-ups for patients with diagnosed osteoporosis   


The USF Diabetes and Endocrinology Center team in collaboration with multiple specialties provides a high level of care for patients with bone loss due to different etiology.


Team Members

  • Iryna_Pestun Dr. Iryna Pestun

    Osteoporosis Program Coordinator


  • Bond-Stefanie Stefanie Bond , PT, DPT

    Board Certified Clinical Specialist in Geriatric Physical Therapy, Lead Physical Therapist – Osteoporosis Program


Providers

  • Dr. Marla Sevilla


  • mesmar-bayan Dr. Bayan Mesmar


  • Dr. Salgado Dr. Silvia Salgado


  • kushchayeva-yevgeniya Dr. Yevgeniya Kushchayeva

    Leader Of The Program


Phone for scheduling the appointment: 813-821-8011

Fax number to fax records: 813-905-8970

Referral Form to be faxed with records


The bone loss due to causes below can be evaluated and treated by our team

  1. Osteoporosis/bone loss/low bone mineral density:
    1. Age-related,
    2. Pre-menopausal and postmenopausal,
    3. Pregnancy and lactation-associated osteoporosis (PLO)
    4. Hypogonadism in men,
    5. Other endocrine-related osteoporosis due to Cushing syndrome/disease, hyperparathyroidism, hyperthyroidism, acromegaly, growth hormone deficiency,
    6. Drug-induced bone loss (including but not limited to glucocorticosteroids, check-point inhibitors, aromatase-inhibitors, androgen-deprivation therapy, suppressive thyroid hormone therapy),
    7. Radiation induced bone loss,
    8. Transplantation-related bone loss,
    9. Malnutrition, bariatric surgery related, vitamin D deficiency, etc.
  2. Bone loss due to genetic disorders such as Osteogenesis imperfecta, McCune-Albright syndrome, Osteoporosis-pseudoglioma syndrome, cystic fibrosis, hypophosphatasia, Hypophosphatemic nephrolithiasis/osteoporosis-1, Paget’s disease of the bone, vitamin D receptor mutation.
  3. Perioperative management of the osteoporosis before and after spinal and orthopedic surgeries.

Osteoporosis screening should be provided based on current recommendations of International Society of Clinical Densitometry (ISCD):

  • Women aged 65 and older,
  • For post-menopausal women younger than age 65 a bone density test is indicated if they have a risk factor for low bone mass such as:  Low body weight, Prior fracture, High risk medication use, Disease or condition associated with bone loss,
  • Women during the menopausal transition with clinical risk factors for fracture, such as low body weight, prior fracture, or high-risk medication use
  • Men aged 70 and older,
  • For men < 70 years of age a bone density test is indicated if they have a risk factor for low bone mass such as low body weight, prior fracture, or high-risk medication use,
  • Adults with a fragility fracture
  • Adults with a disease or condition associated with low bone mass or bone loss
  • Adults taking medications associated with low bone mass or bone loss,
  • Anyone being considered for pharmacologic therapy,
  • Anyone being treated, to monitor treatment effect,
  • Anyone not receiving therapy in whom evidence of bone loss would lead to treatment,
  • Women discontinuing estrogen should be considered for bone density testing according to the indications listed above.

 

Links:

Osteoporosis foundations:
International osteoporosis foundation: https://www.osteoporosis.foundation/
Bone health and osteoporosis foundation: https://www.bonehealthandosteoporosis.org/ 

Fracture risk calculator, American Bone Heath, Healthy Bones Tampa Bay
https://americanbonehealth.org/hbtb/hbtb-resources/
Bone Registry – coming soon.

Bone Health Fall Prevention Interactive House

Anti-osteoporosis medications support programs links:

Teriparatide (Forteo):  
https://www.forteo.com/savings-and-support
https://simplefill.com/forteo-patient-assistance-programs/
https://www.needymeds.org/drug_list.taf?_function=name&name=Forteo
https://www.alvogenteriparatide.com/savings-program/ 

Abaloparatide (Tymlos):
https://www.tymlos.com/savings-support
https://www.needymeds.org/generic-drug/name/abaloparatide  

Romosozumasb (Evenity):
https://www.evenity.com/evenity-support/evenity-cost 

Denosumab (Prolia):
https://www.amgenassist360.com/patient/prolia-cost-assistance
https://www.proliahcp.com/support-and-access/access-overview

Rare Bone Disease Alliance

The Rare Bone Disease Alliance, originally created in 2006 as a patient advocacy network and called the Rare Bone Disease Network, has grown into a strong coalition focused on educating medical professionals, expanding research, and assisting patients and communities affected by rare bone diseases.

The Alliance encourages professional, medical and scientific societies to expand their educational programs on rare bone disease and organizes its own meetings and workshops.

Alliance participants include rare bone disease physician and scientific thought leaders, the Rare Bone Disease Patient (RBDPN) organizations and pharmaceutical companies working in the rare bone field.

Information is available from these Rare Bone Disease Patient Network (RBDPN) organizations:

For information contact Charlene Waldman, Rare Bone Disease Alliance Director
waldmancharlene234@gmail.com

The Rare Bone Disease Alliance is a program of The Osteogenesis Imperfecta Foundation
www.oif.org

Image

Brochures and Infographics [PDFs]


*Not all exercises are suitable for everyone, especially if you have some chronic or recurring conditions, it may result in injury. Please consult with your health care professional before starting any exercise program to determine if it is right for you.  Do not start exercises if your health care provider advises against it. This exercise information is designed for educational purposes only.